The field of medicinal chemistry relies on understanding specific biochemical targets to develop effective therapies. Uridine phosphorylase (UP) is one such target enzyme, critical in nucleotide metabolism and implicated in both cancer and viral infections. Compounds that can inhibit UP, like 2,2'-Cyclouridine (CAS: 3736-77-4), are therefore of immense importance in research. NINGBO INNO PHARMCHEM CO.,LTD. supplies this vital research chemical to facilitate these critical studies.

The 2,2'-Cyclouridine anticancer mechanism is directly linked to its ability to inhibit UP. By blocking this enzyme, 2,2'-Cyclouridine can disrupt the synthesis of pyrimidine nucleotides, which are essential for DNA and RNA replication in rapidly dividing cancer cells. This deprivation can lead to cell cycle arrest and apoptosis, offering a targeted approach to cancer treatment. Understanding this uridine phosphorylase inhibitor for cancer is a key aspect of ongoing oncological research.

Similarly, in 2,2'-Cyclouridine antiviral research, the inhibition of UP can interfere with the viral replication cycle. Many antiviral drugs are nucleoside analogues that require activation by cellular enzymes, including UP. By inhibiting UP, 2,2'-Cyclouridine can modulate the effectiveness of these analogues or directly interfere with viral nucleotide metabolism. This dual functionality highlights the compound's significance in both fighting cancer and viral diseases.

NINGBO INNO PHARMCHEM CO.,LTD. ensures that researchers can easily access high-quality 2,2'-Cyclouridine. When you buy 2,2'-Cyclouridine from us, you are obtaining a meticulously characterized compound that adheres to strict purity standards, critical for reliable research outcomes. The detailed CAS 3736-77-4 chemical properties provide researchers with the necessary information to effectively incorporate it into their experimental designs, advancing the understanding and development of new therapeutic strategies.